Observing a 5.55% increase, the current average has risen from the previous average price target of $163.67. The analysis of recent analyst actions sheds light on the perception of Masimo by ...

About Masimo Masimo (NASDAQ ... such as Radius-7 ®, Radius PPG ®, and Radius VSM™, portable devices like Rad-67 ®, fingertip pulse oximeters like MightySat ® Rx, and devices available ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might seem amusing – as John Gruber wryly noted ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on reducing spending to drive long-term growth. The company continues to evaluate ...

Masimo stock jumped Wednesday after Chief Executive Joe Kiani resigned, while the company's other executives stayed on board.

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Masimo’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 14.63%. Image Source: Zacks Investment Research Let’s delve deeper.

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...

4 analysts have expressed a variety of opinions on Masimo (NASDAQ:MASI ... has risen from the previous average price target of $163.67. Interpreting Analyst Ratings: A Closer Look The analysis ...

Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review ...